C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
12/2002
12/26/2002	US20020197648 High throughput screening methods using magnetic resonance imaging agents
12/25/2002	CN1096862C Controlled-release dosage form of azithromycin
12/24/2002	US6498195 For prophylaxis and therpy of cancer
12/19/2002	WO2002100537A2 Ruthenium catalysts on a si02-based carrier material for catalytic hydrogenation of saccharides
12/19/2002	WO2002100401A1 Soluble cdk-inhibitory indirubin derivatives
12/19/2002	WO2002044190A3 PROCESSES FOR THE PREPARATION OF αGal(1→3)βGal(1→4)Glc-OR
12/19/2002	US20020193446 Compounds and methods for the inhibition of the expression of VCAM-1
12/19/2002	US20020193316 Caloporoside derivatives, methods of their preparation and use
12/19/2002	US20020193315 Having inhibitory activity against diacylglycerol acyltransferase and useful for therapy and prophylaxid of disease of humans such as obesity or hyperlipidemia which is caused by accumulation of triacylglycerol
12/19/2002	US20020193274 Adding a hydrotrope to surfactant, hydrotrope comprising a cationic sugar surfactant containing at least one hydrocarbon group with 6-24 carbon atoms and at least one quaternary ammonium group for increasing solubility
12/18/2002	EP1265840A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
12/18/2002	EP1265587A1 Hair dyes containing cationic biopolymers
12/18/2002	EP0910328B1 Aqueous nacreous lustre concentrate
12/18/2002	CN1096456C Process for continuous extracting soybean isolavone, oligose and saponin
12/18/2002	CN1096455C Process for extracting soybean isoflavone and soybean saponin
12/17/2002	US6495678 Immunosuppressant containing glucopyranose derivative as active ingredient
12/12/2002	WO2002098893A1 Glucopyranosyloxypyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
12/12/2002	WO2002098885A1 Modified psma ligands and uses related thereto
12/12/2002	WO2002090313A8 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies
12/12/2002	WO2002065989A3 Aminoglycoside treatment for lysosomal storage diseases
12/12/2002	US20020188118 Compounds and methods for the inhibition of the expression of VCAM-1
12/12/2002	US20020188113 Dehydrated dextrose monohydrate, preparation and use thereof
12/12/2002	US20020187998 Local ophthalmic agent for treatment of ocular inflammation
12/12/2002	US20020187992 Prodrugs via acylation with cinnamate
12/12/2002	US20020187942 Method for producing beta-D-ribofuranose derivatives or optical isomers thereof
12/12/2002	DE10128205A1 Ruthenium catalysts, useful for the production of sugar alcohols, are prepared by impregnation of an amorphous silicon dioxide support material followed by drying and immediate reduction.
12/12/2002	CA2436408A1 Modified psma ligands and uses related thereto
12/11/2002	EP0880603B1 Oligosaccharide amino alditols and assay method
12/11/2002	EP0807185B9 Antitumor preparations containing a lipoteichoic acid from steptococcus
12/11/2002	CN1384754A Method and composition for treating prostate cancer
12/10/2002	US6492342 Hygromycin A prodrugs
12/10/2002	US6492341 Preparation of fagopyritols and uses therefor
12/10/2002	US6492335 Glycoconjugates from modified camptothecin derivatives (20-O-linkage)
12/05/2002	WO2002096399A1 Lipolysis accelerator, cosmetic skin preparation for body weight reduction and food or beverage composition each containing the same, and method for reducing body weight and medicinal use each based on activity of the same
12/05/2002	US20020183385 Administering a therapeutically effective amount of arsenic compounds to a mammal for treating solid tumor
12/05/2002	US20020183267 For use as antibiotics; for therapy of Staphylococcus aureas infection
12/05/2002	US20020183262 Method for purification of acarbose
12/05/2002	US20020182661 Substrate analogs for MurG, methods of making same and assays using same
12/04/2002	EP1261615A1 Novel techniques for the preparation and crystallization of 4-o-beta-d-galactopyranosyl-d-gluconic acid
12/04/2002	EP1261614A2 Method for the production of perbenzylated 1-o glycosides
12/04/2002	EP1261568A2 Generation and screening of a dynamic combinatorial library
12/04/2002	EP0929234B1 Tablets containing a sweetening mixture
12/04/2002	CN1382691A Process for preparing ketal kelinmycin
12/03/2002	US6489302 Of varous drugs (such as anticancer agents) that make use of glucose transporter to deliver drugs to site of action (such as across blood-brain barrier) more efficiently, thereby reducing side effects
12/03/2002	CA2074933C Thiazole derivatives as active superoxide radical inhibitors
11/2002
11/28/2002	WO2002095393A2 Drug evolution: drug design at hot spots
11/28/2002	WO2002094019A1 Highly purified antiendotoxin compound
11/28/2002	US20020177717 Compounds and methods for the inhibition of the expression of VCAM-1
11/28/2002	US20020177610 Hypolipidemics; treating obesity and disorders of lipid metabolism
11/28/2002	US20020177563 Neutral glycolipid enhances protein C pathway anticoagulant activity.
11/27/2002	EP1260516A1 Method for producing a beta-D-ribofuranose derivative or an optical isomer thereof
11/27/2002	EP1260211A1 Skin preparations for external use
11/27/2002	EP1259523A2 Pluraflavins and derivatives thereof, process for their preparation and use thereof
11/27/2002	EP1259470A2 A group of anti-cancer compounds with specific structure and their production method
11/27/2002	EP1144430A4 Protecting groups for carbohydrate synthesis
11/27/2002	EP0994887B1 Modified glycosides, compositions comprised thereof and methods of use thereof
11/27/2002	CN1382151A Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols
11/27/2002	CN1382150A Hydromycin derivatives
11/27/2002	CN1382149A Hygromycin A prodrugs
11/27/2002	CN1094942C Propiophenone derivatives and process for preparing the same
11/26/2002	CA2095214C Agents for the treatment of diseases caused by parasitic protozoa and neoplastic diseases
11/26/2002	CA2091616C Method for manufacturing powdery crystalline maltitol
11/26/2002	CA2067184C New linker for bioactive agents
11/26/2002	CA2051855C Process for producing n-substituted-1-deoxynojirimycin
11/24/2002	CA2354921A1 Drug evolution: drug design at hot spots
11/21/2002	US20020173471 Anticancer agents
11/21/2002	US20020173452 Cytostatic-glycoconjugates having specifically cleavable linking units
11/21/2002	US20020172658 Bait matrices and bait stations for eliminating termite colonies and
11/20/2002	EP1258490A1 Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates
11/20/2002	EP1257558A1 Methods for synthesis of alpha-d-gal (1- 3) gal-containing oligosaccharides
11/20/2002	EP0831851B1 Use of pseudopterosins for promoting wound healing
11/14/2002	WO2002090369A2 Method for the production of surface active agent mixtures
11/14/2002	WO2002090313A1 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies
11/14/2002	WO2002069704A3 Devices and methods for eliminating termite colonies
11/14/2002	US20020169232 Saccharide-alkyleneoxy derivative and ink
11/14/2002	US20020169215 Treatment of a disease that is mediated by the expression or suppression of a redox sensitive gene, for example MCP-1, IL-6 and thrombin receptor; antiinflammatory agents; cardio-vascular disorders; atherosclerosis; immunology
11/13/2002	EP1256586A1 Galectin recognized photosensitizers for photodynamic therapy
11/13/2002	EP1255764A1 Purine derivatives
11/13/2002	EP1255718A1 A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
11/13/2002	EP1086092B1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE
11/13/2002	EP0904054B1 USE OF alpha-ALKYLGLUCOSIDES AND alpha-ALKYLGLUCOSIDE ESTERS AS ANTI-MICROBIAL EMULSIFYING AGENTS
11/13/2002	CN1379036A Phenylethanol boschnaloside compounds
11/13/2002	CN1379035A Halobiotic Phenylmethanol boschnaloside compounds
11/13/2002	CN1379034A Process for preparing tetra-hexose ganglioside monosialate
11/12/2002	CA2079581C Crystalline etoposide 4'-phosphate diethanolate
11/07/2002	WO2002087632A1 High throughput screening methods using magnetic resonance imaging agents
11/07/2002	WO2002055021A3 Glycopolymers and free radical polymerization methods
11/07/2002	US20020165168 Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances
11/07/2002	US20020164347 Neoglycoproteins
11/07/2002	DE10122255C1 Verfahren zur Herstellung von Tensidgemischen A process for the production of surfactant mixtures
11/06/2002	EP1254890A1 Derivatives of 3,3-diphenylpropylamines
11/06/2002	EP1253924A1 Nitrate salts of antimicrobial agents
11/06/2002	EP0998280A4 Carbohydrate scaffold compounds and libraries
11/06/2002	EP0923528B1 Oligosaccharide synthesis
11/06/2002	EP0883624B1 Tetraether lipids and liposomes containing said lipids, and use of the same
11/05/2002	US6476185 Preparation of an organic compound by a condensation reaction
11/05/2002	US6475992 Methods of and compositions for potentiating the action of agents active on cell wall sites of the susceptible bacteria
11/05/2002	US6475991 Use of α-alkylglucosides and α-alkylglucoside esters as anti-microbial an agents
10/2002
10/31/2002	WO2002086503A1 Bacteriotoxin adsorbents and method of screening the same
10/31/2002	WO2002086142A1 Process for producing soyasapogenol b

1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 180